Silibinin Inhibits the Migration and Invasion of Human Gastric Cancer SGC7901 Cells by Downregulating MMP-2 and MMP-9 Expression Via the P38MAPK Signaling Pathway

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Jan 19

PMID 29344204

Citations 14

Authors

Shuming Lu

Zhuqing Zhang

Meiru Chen

Chunyan Li

Lina Liu

Yan Li

Affiliations

Soon will be listed here.

Abstract

The objective of the present study was to observe the effects of silibinin and the p38 mitogen-activated protein kinase (MAPK) signaling pathway inhibitor SB203580 on the migration and invasion capabilities of SGC7901 cells, and to explore the underlying associated mechanisms. Scratch, Transwell and Matrigel invasion assays were performed to study the effects of silibinin on cell migration and invasion. Western blot analysis was used to determine the expression levels of p38MAPK, phosphorylated (p-)p38MAPK, matrix metalloproteinase (MMP)-2 and MMP-9. At the genomic level, quantitative polymerase chain reaction was performed to evaluate the expression levels of MMP-2 and MMP-9. The results of scratch assay indicated that silibinin inhibited the migration capabilities of human gastric cancer SGC7901 cells in a dose-dependent manner. Additionally, Matrigel invasion and Transwell migration assays revealed that silibinin and SB203580 combined treatment significantly reduced the number of invasive cells. Western blot analysis indicated a reduced phosphorylation of p38MAPK without marked changes in p38MAPK expression. In addition, the expression of MMP-2 and MMP-9 significantly decreased in the presence of silibinin, SB203580, and the combination of silibinin and SB203580. In summary, silibinin decreased the invasion and migration abilities of SGC7901 cells by downregulating the expression of MMP-2 and MMP-9 through inhibiting p38MAPK signaling cascades.

Citing Articles

A new insight on alleviating the inhibitory effect of aflatoxin B1 on muscle development in grass carp (): The effect of 4-Methylesculetin in vivo and in vitro.

He X, Zhang J, Jiang W, Wu P, Liu Y, Ren H Anim Nutr. 2024; 19:339-354.

PMID: 39640553 PMC: 11617288. DOI: 10.1016/j.aninu.2024.08.001.

Cortactin contributes to the tumorigenesis of gastric cancer by activating ERK/MMP pathway.

Zhao Y, Hu F, Wang Q Heliyon. 2023; 9(7):e18289.

PMID: 37539204 PMC: 10395536. DOI: 10.1016/j.heliyon.2023.e18289.

MECP2 promotes the migration and invasion of gastric cancer cells by modulating the Notch1/c-Myc/mTOR signaling pathways by suppressing FBXW7 transcription.

Zhao L, Wang X, Yang J, Jiang Q, Zhang J, Wu F Am J Cancer Res. 2022; 12(11):5183-5204.

PMID: 36504898 PMC: 9729893.

Palmitic Acid Promotes Lung Metastasis of Melanomas via the TLR4/TRIF-Peli1-pNF-κB Pathway.

Zhang X, Li X, Xiong G, Yun F, Feng Y, Ni Q Metabolites. 2022; 12(11).

PMID: 36422271 PMC: 9696090. DOI: 10.3390/metabo12111132.

Cytotoxicity of Mahanimbine from Curry Leaves in Human Breast Cancer Cells (MCF-7) via Mitochondrial Apoptosis and Anti-Angiogenesis.

Hobani Y Molecules. 2022; 27(3).

PMID: 35164236 PMC: 8838323. DOI: 10.3390/molecules27030971.

References

Hulkower K, Herber R . Cell migration and invasion assays as tools for drug discovery. Pharmaceutics. 2013; 3(1):107-24. PMC: 3857040. DOI: 10.3390/pharmaceutics3010107. View

Lali F, Hunt A, Turner S, Foxwell B . The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38.... J Biol Chem. 2000; 275(10):7395-402. DOI: 10.1074/jbc.275.10.7395. View

de Oliveira D, Savio A, de Castro Marcondes J, Barros T, Barbosa L, Salvadori D . Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status. J Biosci. 2017; 42(1):91-101. DOI: 10.1007/s12038-016-9654-5. View

Boukerche H, Aissaoui H, Prevost C, Hirbec H, Das S, Su Z . Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene. 2010; 29(21):3054-66. PMC: 2878370. DOI: 10.1038/onc.2010.65. View

Wu K, Zeng J, Zhu G, Zhang L, Zhang D, Li L . Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Acta Pharmacol Sin. 2009; 30(8):1162-8. PMC: 4006687. DOI: 10.1038/aps.2009.94. View

Pan F, Ma S, Cao W, Liu H, Chen F, Chen X . SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines. Mol Biol Rep. 2013; 40(7):4139-46. DOI: 10.1007/s11033-012-2225-4. View

Polachi N, Bai G, Li T, Chu Y, Wang X, Li S . Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review. Eur J Med Chem. 2016; 123:577-595. DOI: 10.1016/j.ejmech.2016.07.070. View

Guo X, Ma N, Wang J, Song J, Bu X, Cheng Y . Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer. 2008; 8:375. PMC: 2628930. DOI: 10.1186/1471-2407-8-375. View

Dastpeyman M, Motamed N, Azadmanesh K, Mostafavi E, Kia V, Jahanian-Najafabadi A . Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI. Med Oncol. 2011; 29(4):2512-8. DOI: 10.1007/s12032-011-0113-8. View

10.

Koul H, Pal M, Koul S . Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer. 2013; 4(9-10):342-59. PMC: 3863344. DOI: 10.1177/1947601913507951. View

11.

Lee K, Kim S, Kim J . Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells. J Exp Clin Cancer Res. 2009; 28:73. PMC: 2698863. DOI: 10.1186/1756-9966-28-73. View

12.

Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View

13.

Chang H, Chen P, Yang S, Sun Y, Wu S, Hung T . Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Mol Carcinog. 2011; 50(10):811-23. DOI: 10.1002/mc.20756. View

14.

Hidalgo M, Eckhardt S . Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001; 93(3):178-93. DOI: 10.1093/jnci/93.3.178. View

15.

Birkenkamp K, Tuyt L, Lummen C, Wierenga A, Kruijer W, Vellenga E . The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Br J Pharmacol. 2000; 131(1):99-107. PMC: 1572293. DOI: 10.1038/sj.bjp.0703534. View

16.

Weng Y, Cai M, Zhu J, Geng J, Zhu K, Jin X . Matrix metalloproteinase activity in early-stage lung cancer. Onkologie. 2013; 36(5):256-9. DOI: 10.1159/000350304. View

17.

Loukopoulos P, Mungall B, Straw R, Thornton J, Robinson W . Matrix metalloproteinase-2 and -9 involvement in canine tumors. Vet Pathol. 2003; 40(4):382-94. DOI: 10.1354/vp.40-4-382. View

18.

Wang X, Zhou Q, Du J, Zhang H, Lu Y, Su S . Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway. Anticancer Agents Med Chem. 2013; 13(6):923-31. DOI: 10.2174/18715206113139990143. View

19.

Bravo-Cordero J, Hodgson L, Condeelis J . Directed cell invasion and migration during metastasis. Curr Opin Cell Biol. 2012; 24(2):277-83. PMC: 3320684. DOI: 10.1016/j.ceb.2011.12.004. View

20.

Barancik M, Htun P, Strohm C, Kilian S, Schaper W . Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol. 2000; 35(3):474-83. DOI: 10.1097/00005344-200003000-00019. View